Slow reduction of IP-10 Levels predicts HBeAg seroconversion in chronic hepatitis B patients with 5 years of entecavir treatment

MLA

Jiezuan Yang, et al. “Slow Reduction of IP-10 Levels Predicts HBeAg Seroconversion in Chronic Hepatitis B Patients with 5 Years of Entecavir Treatment.” Scientific Reports, vol. 6, Nov. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f8febb185e693e2423e89e1d4780d19b&authtype=sso&custid=ns315887.

APA

Jiezuan Yang, Nengneng Zheng, Hejun Mao, Dong Yan, Jianqin He, Xiao Hu, & Renyong Guo. (2016). Slow reduction of IP-10 Levels predicts HBeAg seroconversion in chronic hepatitis B patients with 5 years of entecavir treatment. Scientific Reports, 6.

Chicago

Jiezuan Yang, Nengneng Zheng, Hejun Mao, Dong Yan, Jianqin He, Xiao Hu, and Renyong Guo. 2016. “Slow Reduction of IP-10 Levels Predicts HBeAg Seroconversion in Chronic Hepatitis B Patients with 5 Years of Entecavir Treatment.” Scientific Reports 6 (November). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f8febb185e693e2423e89e1d4780d19b&authtype=sso&custid=ns315887.